Abivax S.A.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,227.7% | -3,059.4% | – | -1,486.0% | – | -449.8% | – | -1,652.9% | – | – | – | – | |
| – | 14.6% | 16.3% | – | 10.8% | – | 3.7% | – | 12.4% | – | – | – | – | |
| – | 2.5% | – | – | 167.0% | – | 63.4% | – | 313.9% | – | – | – | – | |
| – | 329.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -285.5% | 517.9% | – | -500.0% | – | 121.8% | – | 319.8% | – | – | – | – | |
| – | 6.6% | 5.0% | – | 6.7% | – | 0.6% | – | 0.9% | – | – | – | – | |
| – | -76.2% | -377.6% | – | 340.6% | – | 14.6% | – | 9.3% | – | – | – | – | |
| – | – | – | – | 0.0% | – | 0.0% | – | 0.0% | – | – | – | – | |
| – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| – | -117.3% | – | – | 599.7% | – | -30.3% | – | -342.7% | – | – | – | – | |
| – | 5,248.7% | 9,569.2% | – | 563.5% | – | -105.9% | – | -434.7% | – | – | – | – | |
| – | 3,889.5% | 5,914.1% | – | -568.6% | – | -549.3% | – | -2,113.5% | – | – | – | – | |
| – | -1,289.9% | -3,064.4% | – | -1,492.7% | – | -450.4% | – | -1,653.9% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.